TickrTrends EQT fair value analysis

Swedish Firm EQT Nears Acquisition of Qiagen (QGEN) Amid Bidding War

gurufocus.com · 2026-10-20

On October 20, 2026, Swedish investment firm EQT is reportedly close to finalizing an acquisition deal for Qiagen NV (NYSE: QGEN), with the company's board set

TickrTrends take: EQT's pursuit of Qiagen represents a significant capital deployment that could reshape the Swedish firm's portfolio mix, shifting exposure toward life sciences and diagnostics from its traditional energy sector positioning. A valuation-focused reader should monitor how this acquisition impacts EQT's financial metrics and leverage ratios, particularly given TickrTrends' current undervalued assessment, as major acquisitions can materially alter the risk profile and return expectations that inform that designation. The competitive bidding process may also influence final deal economics and the subsequent accretion or dilution to shareholder value relative to current market pricing.

Read the full story at gurufocus.com →

Is EQT undervalued? See TickrTrends' fair value analysis →